cell therapy
| 1 min read
As drug discovery grows more complex, the pace of discovery increasingly depends on the tools and people working behind the scenes.
| 4 min read
Multibillion dollar oncology deals, first-in-class wins, AI scientists, and more led the news this week.
| 2 min read
ImmunoVec will use a $40.7 million grant to advance its polymeric nanoparticle platform toward a first-in-human trial for autoimmune diseases.
| 2 min read
The state-of-the-art facility will deliver CGMP plasmid DNA development and manufacturing services by late 2025.
| 1 min read
Acquisition supports TQ Therapeutics’ development of ultra-short extracorporeal cell and gene therapy platform
| 6 min read
ArsenalBio equips T cells with multiple weapons to identify, attack, and persist against tumors, bringing the power of CAR T cell technology to solid cancers.
| 4 min read
New data show that NK cell engagers may provide a robust alternative to T cell therapies.
| 1 min read
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
| 4 min read
Bristol Myers Squibb unveiled promising CAR T cell therapy data for severe autoimmune diseases from their Phase 1 clinical trial, offering hope for remission.
| 10 min read
Exhilarated but cautious, researchers are eager to see if CAR T cell therapy offers a one-time treatment for lupus.
